The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker

International Journal of Laboratory Hematology

Volumn 35, Issue 5, 2013, Pages 534-541

  Nagasawa, A ^a   Matsuno, K ^b   Tamura, S ^a,c   Hayasaka, K ^b   Shimizu, C ^b   Moriyama, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Flow cytometry; Monocyte platelet aggregates; Neutrophil platelet aggregates; Platelet activation; Platelet CD62P expression

Indexed keywords

CD41 ANTIBODY; CD45 ANTIBODY; CD45 ANTIGEN; COLLAGEN; HEXAPEPTIDE; ISOTHIOCYANIC ACID; MONOCLONAL ANTIBODY; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATED PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CIRCULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE AGGREGATION; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MICROSCOPY; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

FLOW CYTOMETRY; MONOCYTE-PLATELET AGGREGATES; NEUTROPHIL-PLATELET AGGREGATES; PLATELET ACTIVATION; PLATELET CD62P EXPRESSION;

ADULT; ANTIGENS, CD45; BIOLOGICAL MARKERS; BLOOD PLATELETS; COLLAGEN; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; RECEPTORS, THROMBIN; TIME FACTORS; YOUNG ADULT;

EID: 84884979362     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12051     Document Type: Article

References (19)

1. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007;100:27-40.
2. Michelson AD. Advances in antiplatelet therapy. Hematology American Society of Hematology Education Program Book 2011:62-9.
3. Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human platelet specific protein. Thromb Res 1975;6:543-8.
4. Csaicsich P, Deutinger J, Tatra G. Platelet specific proteins (β-thromboglobulin and platelet factor 4) in normal pregnancy and in pregnancy complicated by preeclampsia. Gynecol Obstet 1989;244:91-5.
5. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-12.
6. Cohen S, Braiman A, Shubinsky G, Ohayon A, Altman A, Isakov N. PKCtheta is required for hemostasis and positive regulation of thrombin-induced platelet aggrega-tion and alpha-granule secretion. Biochem Biophys Res Commun 2009;385:22-7.
7. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87:4925-36.
8. Laura P, Jim T, Murray A, Robert O, Rom K, Gerald Y, Ross B. A rapid flow cytometric technique for the detection of platelet monocyte-complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol 2009;31:430-9.
9. Marquardt L, Anders C, Buggle F, Palm F, Hellstern P, Grau AJ. Leukocyte-platelet aggregates in acute and subacute ischemic stroke. Cerebrovasc Dis 2009;28:276-82.
10. Elalamy I, Chakroun T, Gerotziafas GT, Petropoulou A, Robert F, Karroum A, Elgra-bly F, Samama M-M, Hatmi M. Circulating platelet -leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res 2008;121:843-8.
11. Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL III, Michelson AD. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein 3a after percutaneous coronary intervention: effects of dalteparin or unfractionated heparin in combination with abciximab. Am Heart J 2001;142:790-798.
12. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227-1234. Review.
13. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost 2011;106:827-38.
14. Arazi HC, Badimon JJ. Anti-inflammatory effects of anti-platelet treatment in athero-sclerosis. Curr Pharm Des, 2012;18:4311-4325.
15. Ueno M, Kodall M, Tello-Montollu A, Angio DJ. Role of platelets and antiplatelet therapy in cardiovascular disease. J Atheroscler Thromb 2011;18:431-42.
16. Sharma G, Berger JS. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. J Thromb Thrombolysis 2011;32:201-8.
17. Daubeuf S, Lindorfer MA, Taylor RP, Joly E, Hudrisier D. The direction of plasma membrane exchange between lymphocytes and accessory cells by Trogocytosis is influenced by the nature of the accessory cell. J Immunol 2010;184:1897-908.
18. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-38.
19. Genc H, Dogru T, Tapan S, Tasci I, Bozoglu E, Gok M, Aslan F, Celebi G, Erdem G, Avcu F, Ural AU, Sonmez A. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome. Clin Biochem 2012;45:92-5.